apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

BRAF and MEK inhibitors influence human immune cell phenotype and function (2017) Hoyer S, Eberlein V, Babalija L, Gerer KF, Walter L, Schuler G, Schaft N, et al. Conference contribution Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition (2017) Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, et al. Conference contribution Eosinophilic count as a biomarker for prognosis of melanoma patients (2017) Moreira A, Heinzerling L Conference contribution Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients (2017) Cosgarea , Zimmer L, Weide B, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, et al. Conference contribution Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP) (2017) Offenmüller S, Leiter U, Bernbeck B, Garbe C, Eigentler T, Borkhardt A, Classen CF, et al. Journal article Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions (2017) Hassel JC, Heinzerling L, Aberle J, Baehr O, Eigentler TK, Grimm MO, Gruenwald V, et al. Journal article Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy (2017) Moreira A, Leisgang W, Schuler G, Heinzerling L Journal article Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma (2017) Zimmer L, Apuri S, Eroglu Z, Kottschade LA, Forschner A, Gutzmer R, Schlaak M, et al. Journal article Interest in tanning beds and sunscreen in German-speaking countries (2017) Kirchberger MC, Kirchberger LF, Eigentler TK, Reinhard R, Berking C, Schuler G, Heinzerling L, Heppt MV Journal article A review of serious adverse effects under treatment with checkpoint inhibitors (2017) Heinzerling L, Goldinger SM Journal article